全文获取类型
收费全文 | 540篇 |
免费 | 16篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 3篇 |
妇产科学 | 4篇 |
基础医学 | 42篇 |
口腔科学 | 6篇 |
临床医学 | 51篇 |
内科学 | 34篇 |
皮肤病学 | 7篇 |
神经病学 | 1篇 |
特种医学 | 12篇 |
外科学 | 25篇 |
综合类 | 60篇 |
预防医学 | 29篇 |
眼科学 | 3篇 |
药学 | 271篇 |
中国医学 | 3篇 |
肿瘤学 | 7篇 |
出版年
2023年 | 1篇 |
2022年 | 5篇 |
2021年 | 11篇 |
2020年 | 8篇 |
2019年 | 9篇 |
2018年 | 13篇 |
2017年 | 4篇 |
2016年 | 11篇 |
2015年 | 6篇 |
2014年 | 22篇 |
2013年 | 36篇 |
2012年 | 24篇 |
2011年 | 23篇 |
2010年 | 20篇 |
2009年 | 28篇 |
2008年 | 28篇 |
2007年 | 35篇 |
2006年 | 28篇 |
2005年 | 28篇 |
2004年 | 31篇 |
2003年 | 16篇 |
2002年 | 25篇 |
2001年 | 24篇 |
2000年 | 12篇 |
1999年 | 13篇 |
1998年 | 11篇 |
1997年 | 13篇 |
1996年 | 15篇 |
1995年 | 20篇 |
1994年 | 12篇 |
1993年 | 11篇 |
1992年 | 6篇 |
1991年 | 5篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1986年 | 6篇 |
1984年 | 1篇 |
排序方式: 共有569条查询结果,搜索用时 15 毫秒
101.
目的:研究治疗顽固性支原体阴道炎的有效方法。方法:将110例患者随机分为观察组和对照组各55例,所有患者均以阿奇霉素全身用药治疗,治疗组另给予外用盐酸环丙沙星栓剂。结果:治疗组55例患者49例治愈,占89.09%,好转5例,占9.09%,1例是无效的,占患者总数的1.82%,对照组55例,37例治愈,占67.27%,好转11例,占20%,7例无效,占12.73%,观察组疗效显著优于对照组,差异有显著性(Hc=23.73,P〈0.05)。结论:支原体阴道炎易反复发作,在治疗期间必须采取综合性的治疗,全身给药结合局部用药,可以完全治愈阴道炎反复发作。 相似文献
102.
E. Nani A. Lavitola M. Lembo B. Covelli 《Journal of chemotherapy (Florence, Italy)》2013,25(4):223-225
SummaryThe in vitro antibacterial activity of ciprofloxacin, a new quinoline carboxylic acid, was tested against 1671 recendy clinically isolated bacterial strains, by measuring the minimum inhibitory concentrations (MIC). Comparisons were made with other quinolones: nalidixic acid, norfloxacin, and other drugs: piperacillin, cefoxitin, cefotetan, ceftazidime, tobramycin, rifampin, tetracycline, chloramphenicol.Ciprofloxacin was very active against the tested species and was the most active drug against all the bacterial strains, with a geometric mean, a MIC50 and MIC90 of 0.27, 0.12 and 2 μg/ml, respectively. 相似文献
103.
Viviane Araújo Silva Janiere Pereira da Sousa Hilzeth de Luna Freire Pessôa Andrea Fernanda Ramos de Freitas Henrique Douglas Melo Coutinho Larissa Beuttenmuller Nogueira Alves 《Pharmaceutical biology》2016,54(5):863-867
Context: Ocimum basilicum L. (Lamiaceae), popularly known as basil, is part of a group of medicinal plants widely used in cooking and known for its beneficial health properties, possessing significant antioxidant effects, antinociceptive, and others.Objective: The objective of this study is to determine the pharmacological effects produced on the bacterial strains Staphylococcus aureus and Pseudomonas aeruginosa when standard antibiotics and O. basilicum essential oil are combined.Materials and methods: The extraction of O. basilicum (leaves) components was done by steam distillation. The Minimum inhibitory concentration (MIC) was calculated using microdilution technique, where the oil concentrations varied from 2 to 1024?μg/mL. The combinations of O. basilicum oil with ciprofloxacin or imipenem were analyzed by the checkerboard method where fractional inhibitory concentration (FIC) indices were calculated.Results: Ocimum basilicum essential oil, imipenem, and ciprofloxacin showed respective MIC antibacterial activities of 1024, 4, and 2?μg/mL, against S. aureus. In S. aureus, the oil with imipenem association showed synergistic effect (FIC?=?0.0625), while the oil with ciprofloxacin showed antagonism (FIC value?=?4.25). In P. aeruginosa, the imipenem/oil association showed additive effect for ATCC strains, and synergism for the clinical strain (FIC values?=?0.75 and 0.0625). The association of O. basilicum essential oil with ciprofloxacin showed synergism for clinical strains (FIC value?=?0.09).Conclusion: Ocimum basilicum essential oil associated with existing standard antibiotics may increase their antibacterial activity, resulting in a synergistic activity against bacterial strains of clinical importance. The antibacterial activity of O. basilicum essential oil may be associated with linalool. 相似文献
104.
García-Olmos M Parra A García-Calvo G Ponte C Giménez MJ Aguilar L Soriano F 《International journal of antimicrobial agents》2003,21(6):568-573
Quinolone in vivo bactericidal activity was investigated in a guinea pig pneumonia model using three Streptococcus pneumoniae strains with decreasing susceptibility to ciprofloxacin. Treatment regimens resulted in values of AUC0–24 h and C30 min similar to those of standard oral regimens in human serum. Efficacy was defined as a significant difference in number of viable bacteria in the lungs compared with the control. Ciprofloxacin, levofloxacin and gemifloxacin were effective against the levofloxacin-susceptible strain. Only gemifloxacin achieved a ≥99.9% reduction versus control against the levofloxacin intermediate-resistant strain. Gemifloxacin achieved a 99.69% reduction and was the only quinolone significantly different from the control (P<0.05) against the levofloxacin-resistant strain. Gemifloxacin offers in vivo activity against ciprofloxacin- to levofloxacin-resistant pneumococci. 相似文献
105.
Kusachi S Sumiyama Y Takahashi Y Kato K Mashita K Takeyama H Oda S Kobayashi S 《Journal of infection and chemotherapy》2012,18(2):152-159
Therapeutic options for postoperative infection in gastrointestinal surgery are limited. To identify new treatment alternatives,
the Japan Society for Surgical Infection conducted a multicenter prospective, randomized, controlled clinical trial comparing
the efficacy of intravenous ciprofloxacin (CIP IV) and intravenous meropenem (MEM IV). Between July 2005 and May 2008, the
trial recruited patients who developed postoperative infection or had suspected infectious systemic inflammatory response
syndrome after elective clean-contaminated gastrointestinal surgery. All patients had received prophylactic postoperative
antibiotic treatment. Patients received either intravenous CIP IV 300 mg b.i.d. or MEM IV 500 mg b.i.d. A total of 205 patients
from 31 institutions were enrolled. Of these, 101 were randomized to CIP IV and 104 to MEM IV. There were 100 and 102 in the
intent-to-treat (ITT)/safety population and 75 and 77 in the per-protocol (PP) population. There was no significant difference
between CIP IV and MEM IV in terms of clinical efficacy, bacteriological efficacy, incidence of adverse drug reactions, duration
of antimicrobial treatment, or relapse/reactivation. Overall clinical success PP population) was high in both treatment groups:
85.3% (64/75) for CIP IV and 89.6% (69/77) for MEM IV, although the non-inferiority of CIP IV was not demonstrated (difference
−4.3%, 95% CI −14.8, 6.2). In patients who had undergone upper gastrointestinal surgery, success was 88.5% (23/26) for CIP
IV and 85.2% (23/27) for MEM IV. Intravenous ciprofloxacin is as effective as intravenous meropenem in the empiric therapy
of postoperative infection after gastrointestinal surgery. 相似文献
106.
Comparison of an ELISA and a HPLC for Determination of Ciprofloxacin Residues in Pork 总被引:1,自引:0,他引:1
To determine ciprofloxacin (CPFX) residues in pork, an ELISA and a high-performance liquid chromatography (HPLC) procedure were developed and compared on sensitivity, precision and accuracy. For ELISA, CPFX was converted by an active ester method into CFPX-human serum albumin (CPFX-HSA) and CFPX-bovine serum albumin (CPFX-BSA), and the latter allowed the production of CPFX-specific rabbit antisera for the development of an indirect competitive ELISA procedure. For HPLC, an ODS reverse phase column was used with ultraviolet detection, and triethylamine and acetonitrile (87:13) were employed as mobile phase. The limits of detection (LODs) were 0.32 ng ml -1 for ELISA and 10 ng ml -1 for HPLC. The linear detection ranges were 0.32-5000 ng ml -1 for ELISA and 10-5120 ng ml -1 for HPLC. The coefficients of variation were 4.51-11.50% for ELISA and 0.70-9.10% for HPLC over the range of CPFX concentrations of each method. The mean recovery of HPLC (80.58%) was higher than that of ELISA (66.18%). The results suggested that the ELISA, with its high detection throughput and excellent sensitivity and specificity, could be used as a screening method for CPFX residues in pork. The HPLC, for its great precision and accuracy, was an effective confirmatory method for CPFX residues in pork. 相似文献
107.
Ana Catarina Pinto João Nuno Moreira Sérgio Simões 《Cancer chemotherapy and pharmacology》2009,64(3):445-454
Purpose Combination therapy has generated a significant interest in the clinical setting since certain agents, with known mechanisms
of action and non-overlapping toxicities may increase the therapeutic potential of anticancer drugs by decreasing systemic
toxicity and overcoming drug resistance. Doxorubicin and docetaxel, two standard antineoplastic agents in hormone-refractory
prostate cancer (HRPC) therapy and ciprofloxacin were evaluated singly and in several simultaneous and sequential drug combination
schemes, against PC-3 and LNCaP cell lines.
Methods Cellular viability was determined by the resazurin assay and the assessment of synergism, additivity or antagonism was carried
out by the median effect analysis. The importance of dose, exposure time and type of administration were investigated and
compared.
Results Ciprofloxacin–doxorubicin or docetaxel combinations resulted in prominent additive or synergistic effects in both cell lines,
when the cells were pre-treated with ciprofloxacin. These results suggest a rationale for dose reduction of doxorubicin and
docetaxel in prostate cancer therapy, since the doses needed to achieve 50% cell death may be decreased by approximately 4-
to 15-fold or 3- to 8-fold, respectively, after a pre-treatment with ciprofloxacin. In contrast, the referred combinations
yielded moderate antagonistic effects when used concurrently in this in vitro system.
Conclusions Ciprofloxacin sensitized HRPC cells to doxorubicin or docetaxel-induced growth inhibition and, therefore, may play a role
as chemosensitizing agent in prostate cancer treatment. 相似文献
108.
Spektor Z Jasek MC Jasheway D Dahlin DC Kay DJ Mitchell R Faulkner R Wall GM 《International journal of pediatric otorhinolaryngology》2008,72(1):97-102
OBJECTIVE: Describe the pharmacokinetics of ciprofloxacin and dexamethasone after administration of CIPRODEX Otic Suspension (CIP/DEX) into the middle ears of children. DESIGN: Open-label, single-dose, pharmacokinetic studies, administering four drops of CIP/DEX instilled into each middle ear through the tympanostomy tubes immediately following tube placement. Blood was collected for 6h and analyzed for ciprofloxacin and dexamethasone concentrations using a validated liquid chromatography and tandem mass spectrometry (LC/MS/MS) method. SETTING: The study was conducted through a referral pediatric otolaryngology practice with actual surgical procedures performed in an ambulatory care center. PATIENTS: Twenty-five randomly selected patients, 1-14 years of age (mean age, 5 years), receiving tympanostomy tubes. RESULTS: Peak ciprofloxacin plasma levels were observed at about 1h, with a mean C(max) of 1.33+/-0.96 ng/mL (range <0.5-3.45 ng/mL) and an estimated half-life of 3.0+/-1.2h. Peak dexamethasone plasma levels were observed within 2h with a mean C(max) of 0.90+/-1.04 ng/mL (range <0.05-5.10 ng/mL) and an estimated half-life of 3.9+/-2.9h. CONCLUSION: These results demonstrated low systemic exposure of ciprofloxacin and dexamethasone following topical otic administration in pediatric patients. 相似文献
109.
目的:以细菌内毒素检查方法对乳酸环丙沙星注射液进行热原检查。方法:采用抑制或增强试验,将细菌内毒素检查法与家兔法检测结果作对比。结果:该注射液经一定稀释后对测定无干扰。结论:细菌内毒素检查法适用于检测该注射液。 相似文献
110.
氧氟沙星、环丙沙星抗胆道感染作用的实验研究 总被引:2,自引:0,他引:2
目的观察喹诺酮类抗生素(环丙沙星、氧氟沙星)在胆汁中的代谢过程,为临床医师提供胆道感染时合理选用有效抗生素的理论依据。方法犬为实验动物,行胆总管造瘘,以备留取胆汁标本。静脉滴注氧氟沙星(Ofloxacin)、环丙沙星(Ciprofloxacin)后,留取静脉及胆汁标本,用微生物法测定药物浓度,3P87软件数据处理,得出药物动力学参数。结果静脉滴注氧氟沙星、环丙沙星后,胆汁中主要的代谢参数峰值时间(Tpeakmin)分别为58、72;峰值浓度(Cmaxμg/ml)分别为8.02、8.81;半衰期(T 相似文献